Dual specificity protein kinase
From Proteopedia
| Line 35: | Line 35: | ||
[[3h9f]] - hTTK kinase domain + pyrimidino-diazepin ligand | [[3h9f]] - hTTK kinase domain + pyrimidino-diazepin ligand | ||
| - | [[2x9e]], [[3vqu]], [[3w1f]], [[4bhz]], [[4bi0]], [[4bi1]], [[4bi2]], [[4c4e]], [[4c4f]], [[4c4g]], [[4c4h]], [[4c4i]], [[4c4j]] - hTTK kinase domain + inhibitor | + | [[2x9e]], [[3vqu]], [[3w1f]], [[4bhz]], [[4bi0]], [[4bi1]], [[4bi2]], [[4c4e]], [[4c4f]], [[4c4g]], [[4c4h]], [[4c4i]], [[4c4j]], [[4js8]], [[4jt3]] - hTTK kinase domain + inhibitor |
| - | [[2zmc]] - hTTK | + | [[2zmc]] - hTTK kinase domain |
| - | [[2zmd]] - hTTK | + | [[2zmd]] - hTTK kinase domain (mutant) + inhibitor |
| - | [[3hmn]] - hTTK | + | [[3hmn]] - hTTK kinase domain + ATP |
| - | [[3hmo]] - hTTK | + | [[3hmo]] - hTTK kinase domain + staurosporine |
| - | [[3hmp]] - hTTK | + | [[3hmp]] - hTTK kinase domain + quinazolin ligand |
[[Category:Topic Page]] | [[Category:Topic Page]] | ||
Revision as of 10:03, 26 August 2014
Dual specificity protein kinases are kinases which act as both tyrosine kinase and serine/threonine kinase. CLK1 phosphorylates serine/arginine-rich proteins involved in pre-mRNA processing. The dual specificity protein kinase TTK contains tetra-trico-peptide repeat domain (TPR) which serves as interaction domain between proteins.
Contents |
3D structures of dual specificity protein kinase
Updated on 26-August-2014
CLK1
1z57 – hCLK1 kinase domain + himenialdizine – human
2vag - hCLK1 kinase domain + indole inhibitor
CLK2
3nr9 – hCLK2 kinase domain
CLK3
2eu9 – hCLK3
2exe – hCLK3 kinase domain, phosphorylated
2wu6, 2wu7 – hCLK3 kinase domain + inhibitor
3raw - hCLK3 kinase domain + leucettine
TTK
3cek, 3dbq – hTTK kinase domain
4b94, 4h7x, 4h7y - hTTK TPR domain
3gfw - hTTK kinase domain + pyrolo-pyridin ligand
3h9f - hTTK kinase domain + pyrimidino-diazepin ligand
2x9e, 3vqu, 3w1f, 4bhz, 4bi0, 4bi1, 4bi2, 4c4e, 4c4f, 4c4g, 4c4h, 4c4i, 4c4j, 4js8, 4jt3 - hTTK kinase domain + inhibitor
2zmc - hTTK kinase domain
2zmd - hTTK kinase domain (mutant) + inhibitor
3hmn - hTTK kinase domain + ATP
3hmo - hTTK kinase domain + staurosporine
3hmp - hTTK kinase domain + quinazolin ligand
